Karlsson JOG - Search Results

1

Comment on "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity" Antioxidants 2020, 9, 594.

Stehr JE, Lundström I, Karlsson JOG. Stehr JE, et al. Among authors: karlsson jog. Antioxidants (Basel). 2020 Aug 28;9(9):802. doi: 10.3390/antiox9090802. Antioxidants (Basel). 2020. PMID: 32872241 Free PMC article.

2

Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.

Karlsson JO, Ignarro LJ, Lundström I, Jynge P, Almén T. Karlsson JO, et al. Drug Discov Today. 2015 Apr;20(4):411-21. doi: 10.1016/j.drudis.2014.11.008. Epub 2014 Nov 20. Drug Discov Today. 2015. PMID: 25463039 Free article. Review.

3

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial".

Karlsson JOG, Jynge P, Lundström I, Ignarro LJ. Karlsson JOG, et al. Trials. 2019 Jun 24;20(1):380. doi: 10.1186/s13063-019-3476-3. Trials. 2019. PMID: 31234946 Free PMC article. No abstract available.

4

Evidence that fodipir (DPDP) binds neurotoxic Pt²⁺ with a high affinity: An electron paramagnetic resonance study.

Stehr JE, Lundström I, Karlsson JOG. Stehr JE, et al. Among authors: karlsson jog. Sci Rep. 2019 Nov 1;9(1):15813. doi: 10.1038/s41598-019-52248-9. Sci Rep. 2019. PMID: 31676855 Free PMC article.

5

May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?

Karlsson JOG, Jynge P, Ignarro LJ. Karlsson JOG, et al. Antioxidants (Basel). 2020 Oct 10;9(10):971. doi: 10.3390/antiox9100971. Antioxidants (Basel). 2020. PMID: 33050459 Free PMC article.

6

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx.

Karlsson JOG, Jynge P, Ignarro LJ. Karlsson JOG, et al. Antioxidants (Basel). 2021 Dec 3;10(12):1937. doi: 10.3390/antiox10121937. Antioxidants (Basel). 2021. PMID: 34943040 Free PMC article.

7

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn²⁺ and Oxaliplatin-Associated Pt².

Karlsson JOG, Jynge P, Ignarro LJ. Karlsson JOG, et al. Antioxidants (Basel). 2023 Mar 1;12(3):608. doi: 10.3390/antiox12030608. Antioxidants (Basel). 2023. PMID: 36978857 Free PMC article.

8

Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Karlsson JO, Kurz T, Flechsig S, Näsström J, Andersson RG. Karlsson JO, et al. Transl Oncol. 2012 Dec;5(6):492-502. doi: 10.1593/tlo.12238. Epub 2012 Dec 1. Transl Oncol. 2012. PMID: 23323161 Free PMC article.

9

Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Karlsson JOG, Andersson RG, Jynge P. Karlsson JOG, et al. Transl Oncol. 2017 Aug;10(4):641-649. doi: 10.1016/j.tranon.2017.04.012. Epub 2017 Jun 29. Transl Oncol. 2017. PMID: 28668762 Free PMC article. Review.

10

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca₄Mn(DPDP)₅, MnDPDP and DPDP.

Karlsson JOG, Jynge P. Karlsson JOG, et al. Int J Mol Sci. 2024 Apr 15;25(8):4347. doi: 10.3390/ijms25084347. Int J Mol Sci. 2024. PMID: 38673932 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters